Profile of Dr Kathryn Giblin
Kathryn Giblin is an Associate Director in computational chemistry and machine learning at AstraZeneca UK, working on the application of generative artificial intelligence methods to oncology drug design. She conducted her PhD in cheminformatics and machine learning for polypharmacology and toxicity prediction at the University of Cambridge and has a total of ten years of pharmaceutical drug discovery experience.